Literature DB >> 19134160

Selective rejection of porcine islet xenografts by macrophages.

Yiling Fu1, Xuehong Lu, Shounan Yi, Jingjing Wu, Jennifer M O'Hara, Wayne J Hawthorne, Kelly Hucker, Philip J O'Connell.   

Abstract

BACKGROUND: Our previous study has shown that porcine antigen-primed and CD4+ T cell-activated macrophages are capable of recognition and rejection of porcine xenografts after adoptive transfer. However, whether this is an absolute xenograft specific rejection remains to be confirmed.
METHODS: Mouse islet allografts and neonatal porcine islet cell cluster (NICC) xenografts were admixed and transplanted under the left kidney capsule, and NICC xenografts alone were transplanted under the right kidney capsule of strepotozotocin-induced diabetic NOD-SCID mice. After achievement of normoglycemia, the NOD-SCID recipients were transferred with macrophages purified from NICC transplant NOD-SCID mice reconstituted with CD4+ T cells. Five weeks after macrophage transfer the left kidney with the admixed grafts were removed. Graft survival and function following macrophage transfer was assessed by blood glucose measurement and immunohistochemistry. RESULTS AND
CONCLUSIONS: Adoptive transfer with activated macrophages did not affect the normalized blood glucose levels in NOD-SCID recipients of admixed grafts until left nephrectomy 5 weeks post-macrophage transfer. Insulin-positive and porcine C-peptide-negative mouse islets were detected in the admixed grafts. The surviving mouse islets in the admixed grafts were surrounded but not infiltrated by macrophages. The nephrectomized recipients demonstrated sustained hyperglycemia and completely destroyed NICC xenografts in their remaining right kidneys 8 weeks after macrophage transfer. Taken together, these data provide direct evidence of porcine islet xenograft specific rejection by activated macrophages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19134160     DOI: 10.1111/j.1399-3089.2008.00486.x

Source DB:  PubMed          Journal:  Xenotransplantation        ISSN: 0908-665X            Impact factor:   3.907


  8 in total

Review 1.  T-cell-mediated immunological barriers to xenotransplantation.

Authors:  Joseph Scalea; Isabel Hanecamp; Simon C Robson; Kazuhiko Yamada
Journal:  Xenotransplantation       Date:  2012 Jan-Feb       Impact factor: 3.907

2.  Human CD47 expression permits survival of porcine cells in immunodeficient mice that express SIRPα capable of binding to human CD47.

Authors:  Chunfeng Wang; Hui Wang; Kentaro Ide; Yuantao Wang; Nico Van Rooijen; Hideki Ohdan; Yong-Guang Yang
Journal:  Cell Transplant       Date:  2011-04-29       Impact factor: 4.064

Review 3.  Progress in xenotransplantation: overcoming immune barriers.

Authors:  Megan Sykes; David H Sachs
Journal:  Nat Rev Nephrol       Date:  2022-10-05       Impact factor: 42.439

4.  Adoptive transfer with in vitro expanded human regulatory T cells protects against porcine islet xenograft rejection via interleukin-10 in humanized mice.

Authors:  Shounan Yi; Ming Ji; Jingjing Wu; Xiaoqian Ma; Peta Phillips; Wayne J Hawthorne; Philip J O'Connell
Journal:  Diabetes       Date:  2012-03-08       Impact factor: 9.461

5.  LEA29Y expression in transgenic neonatal porcine islet-like cluster promotes long-lasting xenograft survival in humanized mice without immunosuppressive therapy.

Authors:  L Wolf-van Buerck; M Schuster; F S Oduncu; A Baehr; T Mayr; S Guethoff; J Abicht; B Reichart; N Klymiuk; E Wolf; J Seissler
Journal:  Sci Rep       Date:  2017-06-15       Impact factor: 4.379

Review 6.  The Spleen as an Optimal Site for Islet Transplantation and a Source of Mesenchymal Stem Cells.

Authors:  Naoaki Sakata; Gumpei Yoshimatsu; Shohta Kodama
Journal:  Int J Mol Sci       Date:  2018-05-07       Impact factor: 5.923

Review 7.  Cellular Immune Responses in Islet Xenograft Rejection.

Authors:  Min Hu; Wayne J Hawthorne; Shounan Yi; Philip J O'Connell
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

8.  Neonatal Pig Sertoli Cells Survive Xenotransplantation by Creating an Immune Modulatory Environment Involving CD4 and CD8 Regulatory T Cells.

Authors:  Gurvinder Kaur; Kandis Wright; Payal Mital; Taylor Hibler; Jonathan M Miranda; Lea Ann Thompson; Katelyn Halley; Jannette M Dufour
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.